Monoclonal antibodies as antibacterial therapies: thinking outside of the box
- PMID: 33894132
- DOI: 10.1016/S1473-3099(21)00062-1
Monoclonal antibodies as antibacterial therapies: thinking outside of the box
Conflict of interest statement
MHK reports financial support from the Barnes-Jewish Hospital Foundation outside the area of work commented on here. KDB declares no competing interests.
Comment on
-
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.Lancet Infect Dis. 2021 Sep;21(9):1313-1323. doi: 10.1016/S1473-3099(20)30995-6. Epub 2021 Apr 21. Lancet Infect Dis. 2021. PMID: 33894131 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
